4.3.3 Selective serotonin re-uptake inhibitors

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

251 library items in 4.3.3 Selective serotonin re-uptake inhibitors

Filter results by:

Date Published

NeLM Area

Results filtered by:

Category

4: Central nervous system (remove) , 4.3 Antidepressant drugs (remove) , 4.3.3 Selective serotonin re-uptake inhibitors (remove)

Sort by: Display summary:

Results 1 - 10 of 251

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children

Source: Clinical Toxicology,
Date published: 16/05/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Paediatrics | Poisoning

NeLM Area:

Evidence > Medicines Management > References

Abstract link
2.

NHS Evidence Update (April 2012) of NICE guideline on the treatment and management of depression in adults

Source: NHS Evidence,
Date published: 11/05/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Mood disorders (including depression) | National Institute of Clinical Excellence (NICE)

NeLM Area:

News

Update
3.

Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias

Source: Pediatrics,
Date published: 01/05/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Child and adolescent psychiatry

NeLM Area:

News

Abstract
4.

A survey of patient preferences for a placebo orodispersible tablet

Source: Patient Preference and Adherence,
Date published: 17/04/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Pharmaceutics

NeLM Area:

Evidence > Medicines Management > References

Full text link (PDF)
5.

US FDA issues revised recommendation on the potential risk of arrhythmias associated with citalopram

Source: US FDA,
Date published: 02/04/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Adverse Drug Reactions | Drug Alerts | Food &Drug Administration (FDA) | Mood disorders (including depression)

NeLM Area:

News

US FDA

MHRA
6.

Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): RCT

Source: BMJ,
Date published: 12/03/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Care of Older People | Dementia | Mood disorders (including depression)

NeLM Area:

News

Abstract
7.

Maternal use of selective serotonin reuptake inhibitors, foetal growth, and risk of adverse birth outcomes

Source: Archives of General Psychiatry,
Date published: 06/03/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Drugs in pregnancy | Mood disorders (including depression) | Pregnancy

NeLM Area:

News

Abstract
8.

Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome

Source: Headache,
Date published: 28/02/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | 4.7.4 Antimigraine drugs | Adverse Drug Reactions | Food &Drug Administration (FDA)

NeLM Area:

Evidence > Medicines Management > References

Abstract link
9.

Risk of developing Serotonin Syndrome following concomitant use of tramadol with selective serotonin reuptake inhibitors (SSRIs)

Source: Trent Medicines Information Service,
Date published: 23/02/2012
Review date: 31/12/2013

Category:

4.3.3 Selective serotonin re-uptake inhibitors | 4.7.2 Opioid analgesics | Adverse Drug Reactions | Drug Interactions | Neuromuscular disease

NeLM Area:

Evidence > Medicines Q & A

QA94-4-TramadolSSRIs_final.doc
10.

Cipramil Tablets (citalopram)-Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 08/02/2012

Category:

4.3.3 Selective serotonin re-uptake inhibitors | Mood disorders (including depression) | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes

SPC

Results 1 - 10 of 251

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next